共 23 条
- [1] DOXORUBICIN - EFFECT OF DIFFERENT SCHEDULES ON TOXICITY AND ANTI-TUMOR EFFICACY [J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1989, 25 (05): : 873 - 882
- [2] BOT MA, 1988, BIOCHEM PHARMACOL, V37, P3877
- [3] CALABRESI P, 1990, GOODMAN GILMANS PHAR, P1241
- [4] CIECHANOVER A, 1983, J BIOL CHEM, V258, P9681
- [6] FORSSEN EA, 1983, CANCER RES, V43, P546
- [7] GABIZON A, 1983, CANCER RES, V43, P4730
- [8] PHARMACOKINETICS AND TISSUE DISTRIBUTION OF DOXORUBICIN ENCAPSULATED IN STABLE LIPOSOMES WITH LONG CIRCULATION TIMES [J]. JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1989, 81 (19): : 1484 - 1488
- [9] HARTMAN N, 1982, CANCER CHEMOTH PHARM, V10, P11
- [10] ISRAEL M, 1978, CANCER RES, V38, P365